Cutler Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,600
Closed -$2K 5597
2022
Q3
$2K Sell
19,600
-24,100
-55% -$37.6K ﹤0.01% 4375
2022
Q2
$9K Sell
43,700
-31,000
-41% -$45.7K ﹤0.01% 3329
2022
Q1
$9K Buy
+74,700
New +$147K ﹤0.01% 3739
2020
Q4
Sell
-9,200
Closed -$2K 5719
2020
Q3
$2K Buy
+9,200
New +$55K ﹤0.01% 4189
2020
Q2
Sell
-6,300
Closed -$1K 5086
2020
Q1
$1K Sell
6,300
-44,500
-88% -$357K ﹤0.01% 3881
2019
Q4
$44K Buy
50,800
+43,600
+606% +$317K ﹤0.01% 1718
2019
Q3
$1K Sell
7,200
-7,500
-51% -$60.7K ﹤0.01% 3908
2019
Q2
$10K Sell
14,700
-10,000
-40% -$181K ﹤0.01% 2709
2019
Q1
$23K Buy
24,700
+5,600
+29% +$140K ﹤0.01% 1962
2018
Q4
$1K Sell
19,100
-17,900
-48% -$366K ﹤0.01% 3781
2018
Q3
$36K Sell
37,000
-4,700
-11% -$182K ﹤0.01% 1827
2018
Q2
$119K Sell
41,700
-12,400
-23% -$603K 0.01% 1040
2018
Q1
$180K Sell
54,100
-14,300
-21% -$834K 0.02% 875
2017
Q4
$420K Sell
68,400
-21,400
-24% -$1.5M 0.02% 617
2017
Q3
$1.09M Sell
89,800
-78,000
-46% -$6.18M 0.04% 324
2017
Q2
$3.43M Buy
167,800
+92,000
+121% +$5.63M 0.13% 137
2017
Q1
$611K Sell
75,800
-21,400
-22% -$1.3M 0.03% 564
2016
Q4
$629K Sell
97,200
-46,200
-32% -$1.63M 0.02% 589
2016
Q3
$764K Buy
143,400
+97,600
+213% +$2.09M 0.03% 428
2016
Q2
$7K Sell
45,800
-53,100
-54% -$776K ﹤0.01% 4644
2016
Q1
$82K Buy
98,900
+26,600
+37% +$563K 0.01% 1813
2015
Q4
$134K Buy
+72,300
New +$4.66M 0.01% 1518

Other funds holding CLVS